Best Medicine for Anxiety in Pakistan: What You Should Know Before Taking Anything

If you have searched “best medicine for anxiety in Pakistan,” you are not alone. Millions of Pakistanis are dealing with anxiety in some form, and the search for a medication that will quiet it is one of the most common health-related queries in the country.

But here is the honest truth that most search results will not tell you. There is no single best medicine for anxiety in Pakistan, or anywhere else. Anxiety is not one condition. It is a category of conditions, with different presentations, different underlying causes, and different appropriate treatments. The right medication for one person can be entirely wrong for another. And in many cases, the right answer is not medication alone at all.

This guide is written to give you the information you actually need before considering anxiety medication. What types of medication are used. How they work. What the risks are, particularly with the medications most commonly misused in Pakistan. Why proper psychiatric assessment matters. And when therapy, on its own or alongside medication, is the more effective answer.

If you are dealing with anxiety right now and want to speak with a qualified psychiatrist, FCRC’s clinical team is available for confidential consultation. Contact us to reach our admissions team.

Why “Best Medicine” is the Wrong Question

The instinct to search for the best anxiety medication is completely understandable. Anxiety is exhausting. Persistent worry, racing thoughts, physical tension, panic attacks, sleep disturbance — these symptoms make daily life genuinely difficult, and the desire for a single solution that resolves them is human.

But anxiety medication does not work that way. Different medications work on different neurochemical systems. Different anxiety conditions, generalised anxiety disorder, panic disorder, social anxiety, health anxiety, OCD-spectrum presentations, respond differently to different drug classes. According to the National Institute of Mental Health, anxiety disorders are among the most common mental health conditions globally and respond to a range of treatments depending on type and severity.

This is why qualified psychiatrists do not prescribe anxiety medication based on a single conversation or a generic protocol. They conduct a thorough clinical assessment, identify the specific anxiety condition, screen for co-occurring conditions like depression or substance use, consider medical history and current medications, and only then recommend a treatment plan. The right medication is the one that fits your specific clinical picture, not the one that worked for a friend or scored highest on a forum.

Self-medicating for anxiety, particularly with medications widely available without proper prescription in Pakistan, is one of the most common pathways into prescription drug dependency that we treat at FCRC. The medication that feels like an answer in week one becomes the problem in month six.

The Categories of Anxiety Medication Used in Pakistan

To understand what your psychiatrist may discuss with you, it helps to know what categories of medication exist and what each is designed to do.

SSRIs and SNRIs

Selective Serotonin Reuptake Inhibitors and Serotonin Norepinephrine Reuptake Inhibitors are the first-line medications recommended internationally for most anxiety disorders. According to the National Institute of Mental Health, these medications work by gradually increasing the availability of certain neurotransmitters in the brain, producing a stable reduction in anxiety symptoms over weeks rather than hours.

The advantages are significant. They are not addictive. They produce sustained improvement rather than short-term relief. They treat both anxiety and the depression that frequently accompanies it. They are well-studied and have decades of clinical evidence behind them.

The trade-offs are real. They take four to six weeks to reach full effect. Side effects in the first weeks are common, including nausea, sleep disturbance, and changes in appetite. Stopping them requires gradual tapering under medical supervision. They are not a quick fix.

For most patients with moderate to severe generalised anxiety, panic disorder, or social anxiety, SSRIs and SNRIs are the medications a qualified psychiatrist will typically consider first. The specific choice within these classes depends on the patient’s clinical picture and is a decision that requires psychiatric expertise.

Benzodiazepines

This is the category that requires the most honest and direct discussion in the Pakistani context, because the dependency crisis around these medications is one of the largest growing clinical problems we see at FCRC.

Benzodiazepines, including Xanax (alprazolam), Lexotanil (bromazepam), Ativan (lorazepam), Valium (diazepam), and Rivotril (clonazepam), produce rapid relief of anxiety symptoms. They work within minutes. The relief feels dramatic. For someone in the grip of acute anxiety or a panic attack, the experience of taking a benzodiazepine for the first time can feel like rescue.

This is precisely the problem. The rapid relief is also a trap.

Benzodiazepines work by enhancing the activity of GABA, the brain’s primary inhibitory neurotransmitter. With regular use, the brain adapts. Natural GABA function reduces. The original dose stops working as well, prompting dose increases. Tolerance develops. And within weeks to months of regular use, physiological dependency sets in. Stopping then becomes medically dangerous, with withdrawal symptoms including severe anxiety far beyond the original problem, insomnia, and in serious cases, seizures.

The Mayo Clinic is explicit that benzodiazepines should be used short-term only, typically two to four weeks, and only under careful medical supervision. They are not anxiety treatment in the proper sense. They are short-term symptom suppression, appropriate for specific acute situations and time-limited use. They are not a long-term solution and prescribing them as one is not best practice.

In Pakistan, benzodiazepines are widely available, frequently dispensed without proper prescription oversight, and routinely taken long-term by patients who do not realise they have developed dependency until they try to stop. Prescription drug addiction, particularly to benzodiazepines and pregabalin, is a significant and growing portion of the patients we treat at FCRC. Many of these patients began with anxiety, were prescribed benzodiazepines without adequate clinical management, and now face the dual problem of the original anxiety plus a dependency that is harder to treat than the condition that started it.

If you are taking a benzodiazepine for anxiety, this is not a reason to panic or stop abruptly. Stopping abruptly is itself dangerous. It is a reason to speak with a qualified psychiatrist about whether your current treatment is appropriate and what a safer pathway might look like.

Beta-Blockers

Medications like propranolol are sometimes prescribed for the physical symptoms of anxiety, including racing heart, tremor, and the physiological response to performance anxiety. They do not treat the psychological dimension of anxiety but can be useful for specific situations, particularly performance-related anxiety. They are not addictive but are not appropriate for all patients, especially those with certain cardiovascular or respiratory conditions.

Buspirone

Buspirone is an anxiolytic medication that is not a benzodiazepine and does not produce dependency. It is used for generalised anxiety disorder and works gradually, similar to SSRIs. It is less commonly prescribed in Pakistan than internationally but is a legitimate option that a psychiatrist may consider depending on the clinical picture.

Off-Label Medications

Some psychiatrists use medications outside their primary indication for anxiety, including certain antihistamines for short-term sleep and anxiety relief, and pregabalin for specific anxiety presentations. Pregabalin in particular requires the same caution as benzodiazepines in the Pakistani context — it carries genuine dependency potential and is one of the prescription drugs most frequently misused in Pakistan today.

Why Therapy Matters Alongside Medication

This is the part of the conversation that gets the least attention in popular discussion of anxiety treatment, and it is genuinely the most important.

International clinical guidelines, including those from the World Health Organization, consistently identify Cognitive Behavioural Therapy as a first-line treatment for anxiety disorders, often producing outcomes equivalent to or better than medication alone, particularly for long-term recovery. Research summarised by the American Psychological Association supports CBT as one of the most consistently effective psychological treatments for anxiety conditions. For many patients, the most effective treatment plan combines medication for symptom relief with CBT to address the underlying patterns that sustain anxiety.

Medication can quiet symptoms. It does not teach you the cognitive and behavioural skills that allow you to live with less anxiety long-term. CBT does. The patient who learns to identify catastrophic thinking patterns, challenge them effectively, and respond to anxious physiological sensations without panic carries those skills with them for life. The patient relying on medication alone often finds that anxiety returns when the medication is reduced or stopped.

At FCRC, our mental health and psychiatric care integrates psychiatric assessment and medication management with evidence-based psychological therapy delivered by qualified clinical psychologists. For most anxiety patients, this integrated approach produces better and more sustainable outcomes than either component alone.

If you are considering treatment for anxiety, ask any clinician you consult what therapeutic approaches are available alongside medication. A clinician who offers only medication is offering only part of the answer.

The Risk Pakistanis Need to Know About

A specific pattern repeats often enough at FCRC that it deserves direct discussion.

A patient develops anxiety. They visit a general practitioner, who prescribes a benzodiazepine, often Xanax or Lexotanil, sometimes with a brief explanation, sometimes without. The patient takes the medication and feels significantly better within days. The prescription is renewed, often without further clinical review. Months pass. The dose creeps up because the original dose stops working as well. The patient now needs the medication just to feel normal. By the time they realise something has changed, they have moved from anxiety to anxiety plus dependency.

This is not a rare or unusual story. It is one of the most common pathways into prescription drug dependency we see, and it is largely preventable through proper psychiatric care from the outset.

A qualified psychiatrist will not prescribe a benzodiazepine for ongoing anxiety management. They will use it short-term, if at all, and combine treatment with therapy and longer-term medications that do not produce dependency. A general practitioner without specialist psychiatric training may not have the same clinical caution.

If you are dealing with anxiety in Pakistan, seeing a qualified psychiatrist rather than relying on general practice prescribing is one of the most important decisions you can make for your long-term health. Federal City Rehab Clinic’s Consultant Psychiatrist, Dr. Obaid Ullah Khan, provides comprehensive anxiety assessment and treatment within a clinically rigorous framework that prioritises both immediate relief and long-term safety.

When to See a Psychiatrist for Anxiety

Not every anxious moment requires medication. Anxiety is a normal human emotion and short periods of heightened anxiety in response to life events are not in themselves a clinical problem.

The signs that warrant a psychiatric assessment include anxiety that persists for weeks or months without an obvious external cause, anxiety severe enough to disrupt sleep regularly, panic attacks, anxiety that significantly interferes with work, relationships, or daily functioning, physical symptoms including chest pain, racing heart, or breathing difficulty in the absence of medical explanation, persistent avoidance of normal activities because of anxiety, and anxiety accompanied by depressive symptoms or suicidal thoughts.

If any of these patterns are present, a proper clinical assessment will give you clarity on what you are actually dealing with and what treatment, if any, is appropriate. The assessment itself does not commit you to medication. It simply gives you accurate information about your situation, which is information you cannot get from a search engine or a friend’s recommendation.

If you would like to arrange a confidential psychiatric consultation, FCRC’s admissions team is available 24 hours a day.

What to Expect From a Proper Anxiety Assessment

A qualified psychiatric assessment for anxiety should cover several specific areas.

A detailed history of your symptoms, including when they started, what triggers them, how they have changed over time, and how they are affecting your daily life. A medical history to rule out physical conditions that can produce anxiety symptoms, including thyroid disorders, cardiac conditions, and certain medication effects. A mental health history covering any previous episodes of anxiety or depression, family history of mental health conditions, and current life stressors. A substance uses history because alcohol, caffeine, recreational drugs, and prescription medications all interact significantly with anxiety. And a discussion of your goals and preferences for treatment, including how you feel about medication and therapy options.

The outcome of this assessment should be a clear explanation of what you are experiencing, the treatment options available, the realistic expectations and potential risks of each, and a recommendation tailored to your specific situation. You should leave the consultation understanding what is happening to you and what the path forward looks like.

If a clinician does not provide this level of clinical depth, the assessment was not adequate.

Lifestyle and Self-Help — What Actually Helps

Alongside any clinical treatment, several non-pharmacological factors significantly affect anxiety outcomes and are worth taking seriously.

Sleep is foundational. Chronic sleep deprivation directly worsens anxiety, and improving sleep often improves anxiety symptoms substantially before any other intervention. Caffeine reduction matters more than most people realise. Many patients dealing with anxiety in Pakistan are consuming caffeine at levels that directly worsen their symptoms and would not need medication if they reduced it. Regular physical activity has consistent evidence for anxiety reduction, comparable in effect to some medications for mild to moderate anxiety. Limiting alcohol is essential because alcohol initially reduces anxiety but rebounds significantly, often producing worse anxiety the day after drinking. Mindfulness and breathing exercises, when practised regularly, build the physiological regulation skills that reduce baseline anxiety over time.

These are not substitutes for clinical treatment in moderate to severe anxiety. But they are genuine factors that improve outcomes alongside any treatment plan and are worth implementing whether or not you are taking medication.

Anxiety and Other Conditions

A significant proportion of patients presenting with anxiety also have a co-occurring condition that requires attention. Depression is the most common, occurring alongside anxiety in approximately half of all clinically significant anxiety presentations. Substance use, including alcohol and prescription drugs, frequently develops as patients self-medicate untreated anxiety. Other psychiatric conditions including bipolar disorder, PTSD, and OCD can present with prominent anxiety symptoms and require different treatment than primary anxiety disorders.

This is one of the reasons that proper psychiatric assessment matters. The treatment for anxiety with co-occurring depression differs from anxiety alone. The treatment for anxiety in someone with developing alcohol dependency must address both. The treatment for anxiety in a patient with undiagnosed PTSD will fail if the PTSD remains unaddressed. FCRC’s dual diagnosis treatment is specifically designed for these complex presentations.

If your anxiety has not responded to previous treatment attempts, a comprehensive reassessment by a qualified psychiatrist is often the difference between continued struggle and meaningful recovery.